Molecular Surveillance In Early Breast Cancer Using The Tumor-Informed ctDNA Assay Myriad Genetics Precise MRD Test; A Prospective Observational Multicenter Study (The MRD Molecular Surveillance Study)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Novartis
University Hospital, Lille
Peking University Cancer Hospital & Institute
University Hospital, Grenoble
Hospices Civils de Lyon
AURA Health Technologies
University Hospitals of North Midlands NHS Trust
Sichuan Cancer Hospital and Research Institute
Assiut University
Sohag University
Norwegian Institute of Public Health
University of Maryland, Baltimore
Clinica Universidad de Navarra, Universidad de Navarra
KU Leuven
Assiut University
Silesian Hospital in Opava
Incheon St.Mary's Hospital
Azienda Sanitaria Locale CN2 Alba-Bra
Samsung Medical Center
Gangnam Severance Hospital
West China Hospital
Hubei Cancer Hospital
Second Affiliated Hospital, School of Medicine, Zhejiang University
Atlas University
Region Jönköping County
Hubei Cancer Hospital
Hubei Cancer Hospital
Hubei Cancer Hospital
OncoHost Ltd.
Pfizer
Pfizer
IRCCS San Raffaele
Golestan University of Medical sciences
University Hospital, Caen
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
M.D. Anderson Cancer Center
Zhejiang Hospital
Sohag University
Zhejiang Cancer Hospital
Centre Hospitalier Universitaire de Besancon
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Assiut University
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Assiut University
Assiut University
Chang Gung Memorial Hospital
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Case Comprehensive Cancer Center
Tianjin Medical University Cancer Institute and Hospital